Association between insertion/deletion polymorphism in angiotensin-converting enzyme gene and acute lung injury/acute respiratory distress syndrome: a meta-analysis

BMC Medical Genetics

Volumn 13, Issue , 2012, Pages

  Matsuda, Akihisa ^a,b   Kishi, Taro ^c   Jacob, Asha ^a,b   Aziz, Monowar ^b   Wang, Ping ^a,b  

^a DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

Acute lung injury (ALI); Acute respiratory distress syndrome (ARDS); Angiotensin converting enzyme (ACE) gene; Meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ALLELE; ARTICLE; ASIAN; COCHRANE LIBRARY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; EMBASE; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; HUMAN; MEDLINE; META ANALYSIS; MORTALITY;

ACUTE LUNG INJURY; CASE-CONTROL STUDIES; GENE DELETION; HUMANS; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RISK FACTORS; SURVIVAL RATE;

EID: 84865548691     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-13-76     Document Type: Article

References (40)

1. Ware LB. Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin Respir Crit Care Med 2006, 27:337-349. 10.1055/s-2006-948288, 16909368.
2. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000, 342:1334-1349. 10.1056/NEJM200005043421806, 10793167.
3. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994, 149:818-824.
4. Hudson LD, Milberg JA, Anardi D, Maunder RJ. Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1995, 151:293-301.
5. Flores C, Pino-Yanes MM, Casula M, Villar J. Genetics of acute lung injury: past, present and future. Minerva Anestesiol 2010, 76:860-864.
6. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346. 10.1172/JCI114844, 296868, 1976655.
7. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205. 1682892, 1319114.
8. Hu Z, Jin X, Kang Y, Liu C, Zhou Y, Wu X, Liu J, Zhong M, Luo C, Deng L, et al. Angiotensin-converting enzyme insertion/deletion polymorphism associated with acute respiratory distress syndrome among caucasians. J Int Med Res 2010, 38:415-422.
9. Qi Y, Sun J, Zhu T, Wang W, Liu J, Zhou W, Qiu C, Zhao D. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with high-altitude pulmonary oedema: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011, 12:617-623. 10.1177/1470320311406572, 21525147.
10. Qin YH, Zhou TB, Su LN, Lei FY, Huang WF, Zhao YJ. Association between ACE polymorphism and risk of IgA nephropathy: a meta-analysis. J Renin Angiotensin Aldosterone Syst 2011, 12:215-223. 10.1177/1470320310391835, 21357308.
11. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ. Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Gene Polymorphism and Susceptibility of Minimal Change Nephrotic Syndrome: A Meta-Analysis. Int J Nephrol 2011, 360357. http://www.ncbi.nlm.nih.gov/pubmed?term=Relationship%20between%20%20Angiotensin-Converting%20Enzyme%20Insertion%2FDeletion%20Gene%20Polymorphism%20and%20%20Susceptibility%20of%20Minimal%20Change%20Nephrotic%20Syndrome%3A%20A%20Meta-Analysis.
12. Zhou TB, Qin YH, Su LN, Lei FY, Huang WF, Zhao YJ, Pang YS, Yang KP. The association between angiotensin-converting enzyme insertion/deletion gene variant and risk of focal segmental glomerulosclerosis: a systematic review and meta-analysis. J Renin Angiotensin Aldosterone Syst 2011, 12:624-633. 10.1177/1470320311410584, 21652690.
13. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet 2001, 29:306-309. 10.1038/ng749, 11600885.
14. Kishi T, Tsunoka T, Ikeda M, Kawashima K, Okochi T, Kitajima T, Kinoshita Y, Okumura T, Yamanouchi Y, Inada T, et al. Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis. J Hum Genet 2009, 54:629-633. 10.1038/jhg.2009.84, 19730445.
15. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ, Humphries SE, Hill MR, Laurent GJ. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002, 166:646-650. 10.1164/rccm.2108086, 12204859.
16. Jerng JS, Yu CJ, Wang HC, Chen KY, Cheng SL, Yang PC. Polymorphism of the angiotensin-converting enzyme gene affects the outcome of acute respiratory distress syndrome. Crit Care Med 2006, 34:1001-1006. 10.1097/01.CCM.0000206107.92476.39, 16484896.
17. Lu XM, Chen GJ, Yang Y, Qiu HB. Angiotensin-converting enzyme polymorphism affects outcome of local Chinese with acute lung injury. Respir Med 2011, 105:1485-1490. 10.1016/j.rmed.2011.06.009, 21742477.
18. Adamzik M, Frey U, Sixt S, Knemeyer L, Beiderlinden M, Peters J, Siffert W. ACE I/D but not AGT (-6)A/G polymorphism is a risk factor for mortality in ARDS. Eur Respir J 2007, 29:482-488. 10.1183/09031936.00046106, 17107992.
19. Chan KC, Tang NL, Hui DS, Chung GT, Wu AK, Chim SS, Chiu RW, Lee N, Choi KW, Sung YM, et al. Absence of association between angiotensin converting enzyme polymorphism and development of adult respiratory distress syndrome in patients with severe acute respiratory syndrome: a case control study. BMC Infect Dis 2005, 5:26. 10.1186/1471-2334-5-26, 1090578, 15819995.
20. Plunkett A, Agbeko RS, Li K, Humphries SE, Klein NJ, Peters MJ. Angiotensin-converting enzyme D allele does not influence susceptibility to acute hypoxic respiratory failure in children. Intensive Care Med 2008, 34:2279-2283. 10.1007/s00134-008-1260-z, 18787808.
21. Villar J, Flores C, Perez-Mendez L, Maca-Meyer N, Espinosa E, Blanco J, Sanguesa R, Muriel A, Tejera P, Muros M, et al. Angiotensin-converting enzyme insertion/deletion polymorphism is not associated with susceptibility and outcome in sepsis and acute respiratory distress syndrome. Intensive Care Med 2008, 34:488-495. 10.1007/s00134-007-0937-z, 18060663.
22. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009, 339:b2535. 10.1136/bmj.b2535, 2714657, 19622551.
23. Wheeler AP, Bernard GR. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 2007, 369:1553-1564. 10.1016/S0140-6736(07)60604-7, 17482987.
24. Zintzaras E. The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies. Stat Appl Genet Mol Biol 2010, 9:Article21.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
26. Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov 2011, 8:1. 10.1186/1742-5573-8-1, 3041648, 21288353.
27. Egger M. Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634. 10.1136/bmj.315.7109.629, 2127453, 9310563.
28. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101. 10.2307/2533446, 7786990.
29. Adamzik M, Frey UH, Rieman K, Sixt S, Beiderlinden M, Siffert W, Peters J. Insertion/deletion polymorphism in the promoter of NFKB1 influences severity but not mortality of acute respiratory distress syndrome. Intensive Care Med 2007, 33:1199-1203. 10.1007/s00134-007-0649-4, 17468848.
30. Yamamoto T, Wang L, Shimakura K, Sanaka M, Koike Y, Mineshita S. Angiotensin II-induced pulmonary edema in a rabbit model. Jpn J Pharmacol 1997, 73:33-40. 10.1254/jjp.73.33, 9032132.
31. Lambert DW, Clarke NE, Turner AJ. Not just angiotensinases: new roles for the angiotensin-converting enzymes. Cell Mol Life Sci 2010, 67:89-98. 10.1007/s00018-009-0152-x, 19763395.
32. Yokoyama T, Sekiguchi K, Tanaka T, Tomaru K, Arai M, Suzuki T, Nagai R. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am J Physiol 1999, 276:H1968-1976.
33. Behnia R, Molteni A, Igic R. Angiotensin-converting enzyme inhibitors: mechanisms of action and implications in anesthesia practice. Curr Pharm Des 2003, 9:763-776. 10.2174/1381612033455413, 12570793.
34. Igic R, Behnia R. Properties and distribution of angiotensin I converting enzyme. Curr Pharm Des 2003, 9:697-706. 10.2174/1381612033455459, 12570787.
35. Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B, Yang P, Sarao R, Wada T, Leong-Poi H, et al. Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005, 436:112-116. 10.1038/nature03712, 16001071.
36. Wang R, Zagariya A, Ibarra-Sunga O, Gidea C, Ang E, Deshmukh S, Chaudhary G, Baraboutis J, Filippatos G, Uhal BD. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999, 276:L885-889.
37. Hagiwara S, Iwasaka H, Matumoto S, Hidaka S, Noguchi T. Effects of an angiotensin-converting enzyme inhibitor on the inflammatory response in in vivo and in vitro models. Crit Care Med 2009, 37:626-633. 10.1097/CCM.0b013e3181958d91, 19114890.
38. He X, Han B, Mura M, Xia S, Wang S, Ma T, Liu M, Liu Z. Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats. Shock 2007, 28:106-111. 10.1097/SHK.0b013e3180310f3a, 17510605.
39. Wang R, Ibarra-Sunga O, Verlinski L, Pick R, Uhal BD. Abrogation of bleomycin-induced epithelial apoptosis and lung fibrosis by captopril or by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2000, 279:L143-151.
40. Sawcer S. Bayes factors in complex genetics. Eur J Hum Genet 2010, 18:746-750. 10.1038/ejhg.2010.17, 2987358, 20179745.